Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ARENA PHARMACEUTICALS INC | Financial_Report.xls |
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ARENA PHARMACEUTICALS INC | d268596dex211.htm |
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARENA PHARMACEUTICALS INC | d268596dex311.htm |
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ARENA PHARMACEUTICALS INC | d268596dex232.htm |
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ARENA PHARMACEUTICALS INC | d268596dex231.htm |
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARENA PHARMACEUTICALS INC | d268596dex312.htm |
EX-3.8 - CERTIFICATE OF DESIGNATIONS - ARENA PHARMACEUTICALS INC | d268596dex38.htm |
10-K - FORM 10-K - ARENA PHARMACEUTICALS INC | d268596d10k.htm |
EX-10.36 - AMENDMENT NO.5 TO THE TOLL MANUFACTURING AGREEMENT - ARENA PHARMACEUTICALS INC | d268596dex1036.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Arena Pharmaceuticals, Inc. (Arena) for the period ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the Report), Jack Lief, as President and Chief Executive Officer of Arena, and Robert E. Hoffman, as Vice President, Finance and Chief Financial Officer of Arena, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
1. | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Arena. |
/s/ JACK LIEF |
/s/ ROBERT E. HOFFMAN | |||
Jack Lief | Robert E. Hoffman | |||
President and Chief Executive Officer | Vice President, Finance and Chief Financial Officer | |||
Date: March 15, 2012 |
Date: March 15, 2012 |